No Detail Found!

Single Blind, Placebo Control Phase III Study of Insty Granules to Evaluate its Efficacy and Safety.

Author(s)
Faheem Akhtar Department of Research and Development, Herbion Pharmaceutical (Pvt.) Limited, Karachi, Pakistan
Khan Usmanghani Department of Research and Development, Herbion Pharmaceutical (Pvt.) Limited, Karachi, Pakistan
Muhammad Daniyal Department of Medical Affairs and Training, Herbion Pharmaceutical (Pvt.) Limited, Karachi, Pakistan
Muhammad Ibrar Shinwari Department of Environmental Sciences, Faculty of Basic & Applied Sciences, International Islamic University, H-10, Islamabad, Pakistan
Muhammad Khalid Adhia Hamdard University Hospital, Taj Medical Complex, Karachi, Pakistan
Syed Faisal Zaidi Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdul Aziz University of Health Sciences, Jeddah, Saudi Arabia
Syed Rashid Ali Jaffary Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Syed Waseemuddin Ahmed Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Abstract
Aims and Objectives: Cold symptoms are well recognized as sore throat, nasal congestion and clogging, sneezing, coughing, headache and fatigue. This clinical trial was conducted to evaluate the efficacy and safety of Insty granules, at Taj Medical Complex Hamdard Hospital. Introduction: Up to 499.99 million incidents of acute upper respiratory tract infection (i.e. the common cold) are estimated in the United States each year, with a cost associated with 39.99 billion dollars yearly. The common cold is one of the leading causes of work or school absenteeism and is responsible for an estimated 110 million doctor visits and 6 million emergency visits each year in the United States. Method: This was a single blind, placebo control phase III clinical trial. Total 662 patients were enrolled in the study, in which 331 receive the Insty granules and 331 receive the placebo. The age range of patients was 19 years to above 50 years. The sample paired t-test was applied to evaluate the significant level. Results: Insty granules was very effective in the treatment of cold and flu symptoms. Conclusion: The Insty granules was safe and well tolerated in all patients and none of the patient reported any side effect.
Publication Details
Page(s) 2-10
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 5, Issue: 3, Year: 2017

Request the full text from PASTIC

Keywords
herbal treatment, upper-respiratory tract infection, controlled single-blind phase III study, common cold
References
RosensteinN,PhillipsWR,GerberMA,MarcySM,SchwartzB,DowellSF, 1998.The common coldprinciples of judicious use of antimicrobial agents,Pediatrics 101 181 -4
FendrickAM,MontoAS,NightengaleB,SarnesM., 2003.The economic burden of non-influenza-related viral respiratory tract infection in the United States,Ann Intern Med 163 487 -94
2013., -
TurnerRB, 1997.Epidemiology, pathogenesis, and treatment of the common cold,Ann Allergy Asthma Immunol 78 531 -9
NationalHospital Ambulatory Medical Care Survey, 2010., -
EbellMH,LundgrenJ,YoungpairojS., 2013.How long does a cough last? Comparing patients' expectations with data from a systematic review of the literature,Ann Fam Med 11 5 -13
RoxasM,JurenkaJ, 2007.Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations,Altern Med Rev 12 25 -48
0

Citations

0

Downloads

33

Views